Roughly a third of American adults take a daily multivitamin, and the global supplement industry crossed $150 billion last year. The implicit promise is that a single pill plugs nutritional gaps, fends off chronic disease, and provides cheap insurance against whatever your diet missed yesterday. It’s an attractive story. It’s also one that several decades of large, well-designed studies have steadily failed to support for the average healthy adult.
This isn’t a fringe claim. It’s the position of the U.S. Preventive Services Task Force, which in 2022 reaffirmed that there’s insufficient evidence to recommend multivitamins for preventing cardiovascular disease or cancer in healthy adults.
The evidence has been remarkably consistent
The Physicians’ Health Study II followed roughly 14,000 male doctors for over a decade and found a small reduction in cancer incidence but no effect on heart disease, stroke, or mortality. The VITAL trial, with nearly 26,000 participants, found no benefit from vitamin D or omega-3 supplementation on the primary outcomes it measured. The COSMOS study published in 2024 found a modest cognitive benefit from a multivitamin in older adults, which generated headlines, but the effect size was small and the population was already at the age where deficiencies become more common. Across hundreds of studies, the pattern is that healthy adults eating a varied diet don’t see meaningful improvements from adding a multivitamin. The benefits, when they appear, tend to cluster in older adults, pregnant women, and people with documented deficiencies—exactly the groups for whom targeted supplementation already makes sense.
Why the gap between evidence and behavior
If the evidence is this clear, why does the industry keep growing? Part of it is that “no significant benefit” is a much harder message to land than “boost your immunity.” Part of it is regulatory: U.S. supplements aren’t required to demonstrate efficacy before being sold, only safety, and even safety enforcement is famously thin. Part of it is psychological—taking a pill feels like doing something, and that feeling is genuinely valuable to people, even if the biochemistry isn’t pulling its weight. Add aggressive influencer marketing and the cultural assumption that more nutrients must be better, and you get a category that thrives despite, not because of, the trial data.
When supplements actually make sense
This isn’t an argument against all supplementation. Pregnant women genuinely benefit from folate. Vegans need B12. Older adults often have low vitamin D. People with certain medical conditions, restrictive diets, or absorption issues have real, documented deficiencies that targeted supplements correct. The case against multivitamins is specifically the case against unfocused, blanket supplementation in healthy adults who eat reasonably well. For that population, the daily pill mostly produces expensive urine and a sense of conscientiousness.
Bottom line
Multivitamins aren’t dangerous, and they aren’t pointless for everyone. But for most healthy adults eating a normal varied diet, they don’t deliver what the marketing promises, and the studies keep saying so. If you’re worried about a specific deficiency, get tested and address it directly. The shotgun approach has had its decades to prove itself, and it hasn’t.
Leave a Reply